Ardelyx, Inc.
(NASDAQ:ARDX)
$3.34
-0.23 (-6.44%)
At Close: 4:00 PM
$3.25
0.02 (0.62%)
Pre Market: 5:45 AM
Ardelyx Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
Ardelyx Stock Price Today
Ardelyx, Inc. (ARDX) stock declined over -6.44% intraday to trade at $3.34 a share on NASDAQ. The stock opened with a loss of -0.84% at $3.54 and touched an intraday high of $3.55, falling -6.44% against the last close of $3.57. The Ardelyx, Inc. in stock market went to a low of $3.43 during the session.
Ardelyx Stock Snapshot
$3.57
Prev. Close
956.45 Million
Market Cap
$3.43
Day Low
$3.54
Open
207.02 Million
Number of Shares
$3.55
Day High
N/A
P/E ratio
-0.40
EPS (TTM)
0.61
Cash Flow per Share
9.86
Free Float in %
0.58
Book Value
4130312.00
Volume
Ardelyx Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 2023-02-14 | $3.16 | $3.26 | $2.99 | $3.07 | 6401750.00 |
| 2023-02-13 | $3.22 | $3.24 | $3.10 | $3.14 | 3407200.00 |
| 2023-02-10 | $3.27 | $3.30 | $3.18 | $3.21 | 3190700.00 |
| 2023-02-08 | $3.30 | $3.42 | $3.28 | $3.28 | 3765553.00 |
| 2023-02-07 | $3.25 | $3.35 | $3.12 | $3.35 | 4949700.00 |
| 2023-02-06 | $3.08 | $3.37 | $3.07 | $3.22 | 5922000.00 |
| 2023-02-03 | $2.98 | $3.29 | $2.98 | $3.08 | 8110157.00 |
| 2023-02-02 | $3.00 | $3.11 | $2.90 | $3.07 | 4677800.00 |
| 2023-02-01 | $2.93 | $3.04 | $2.89 | $3.01 | 3853000.00 |
| 2023-01-31 | $2.78 | $3.02 | $2.78 | $2.93 | 5271000.00 |
Contact Details
Company Information
Employees133.00
Beta1.19
Sales or Revenue$63.06 Million
5Y Sales Change4.40%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryBiotechnology
About Company
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult patients with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia. It is also developing RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease; and RDX020, an early-stage program in metabolic acidosis, a serious electrolyte disorder in patients with CKD. The company has agreements with Kyowa Kirin in Japan, Fosun Pharmaceutical Industrial Development Co. Ltd. in China, and Knight Therapeutics, Inc. in Canada for the development and commercialization of tenapanor in their respective territories. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Frequently Asked Questions
What is the current Ardelyx, Inc. (ARDX) stock price?
Ardelyx, Inc. (NASDAQ: ARDX) stock price is $3.34 in the last trading session. During the trading session, ARDX stock reached the peak price of $3.55 while $3.43 was the lowest point it dropped to. The percentage change in ARDX stock occurred in the recent session was -6.44% while the dollar amount for the price change in ARDX stock was -$0.23.
ARDX's industry and sector of operation?
The NASDAQ listed ARDX is part of Biotechnology industry that operates in the broader Healthcare sector. Ardelyx, Inc. , a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally.
Who are the executives of ARDX?
Mr. Robert Felsch
Senior Vice President of Fin. & Chief Accounting Officer
Dan Pavicich
Senior Director of Market Devel.
Ms. Kimia Keshtbod
Mang. of Corporation Communications & Investor Relations
Mr. Michael G. Raab
Pres, Chief Executive Officer & Director
How ARDX did perform over past 52-week?
ARDX's closing price is 8.59% higher than its 52-week low of $0.49 where as its distance from 52-week high of $5.125 is -0.08%.
How many employees does ARDX have?
Number of ARDX employees currently stands at 133.00. ARDX operates from 400 Fifth Avenue</br>Waltham, MA 02451</br>US.
Link for ARDX official website?
Official Website of ARDX is: https://www.ardelyx.com
How do I contact ARDX?
ARDX could be contacted at phone #510 745 1700 and can also be accessed through its website. ARDX operates from 400 Fifth Avenue</br>Waltham, MA 02451</br>US.
How many shares of ARDX are traded daily?
ARDX stock volume for the day was 4130312.00 shares. The average number of ARDX shares traded daily for last 3 months was 7.14 Million.
What is the market cap of ARDX currently?
The market value of ARDX currently stands at $956.45 Million with its latest stock price at $3.34 and 207.02 Million of its shares outstanding.